NEW YORK (TheStreet) -- CHANGE IN RATINGS
American Eagle (AEO) upgraded at Wells from Market Perform to Outperform. New management team appears to be turning the business around. Estimates also boosted.
Comerica (CMA) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Valuation call, based on a $32 price target. Estimates also cut.
Comerica upgraded at Stifel from Sell to Hold, Stifel Nicolaus said. Stock is attractively valued, trading below tangible book value.CSX (CSX) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $20 price target. Lower coal volume will likely remain a headwind to growth. Duke Energy (DUK) upgraded at Citigroup to Buy from Neutral, Citigroup said. $72 price target. Carolina concerns priced in. East West Bancorp (EWBC) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $24 price target. Company is seeing strong growth across the board and boosted guidance. ICF International (ICFI) downgraded to hold at TheStreet Ratings. McMoran Exploration (MMR) rated new Buy at Guggenheim. Company appears to be at an inflection point. Annaly Capital (NLY) upgraded at Wells from Underperform to Market Perform, Wells Fargo said. Stock is already factoring in higher expected prepayments. Noble Corporation (NE) downgraded to hold at TheStreet Ratings. Reinsurance Group (RGA) downgraded at KBW from Outperform to Market Perform, Keefe, Bruyette & Woods said. $67 price target. Company is realizing lower earnings. St. Jude (STJ) downgraded at Canaccord from Buy to Hold, Canaccord Geuity said. $43 price target. Company is seeing lower sales demand. St. Jude downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $42 price target. Core business is facing increased growth headwinds. Questar Corp (STR) downgraded at Citigroup to Neutral from Buy, Citigroup said. $21.75 price target. Valuation call. Stryker (SYK) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. $56 price target. Lower near- term drivers. Tibco (TIBX) upgraded at Macquarie from Neutral to Outperform, Macquarie said. $33 price target. Pullback has created an attractive entry point. Xylem (XYL) downgraded at Ladenburg from Buy to Neutral, Ladenburg Thalmann said. Company faces headwinds in Europe and has limited exposure to an improving U.S. housing market.
STOCK COMMENTS / EPS CHANGESAlign Technology (ALGN) numbers lowered at Credit Suisse. Shares of ALGN now seen reaching $30, according to Credit Suisse. Estimates also cut, as the company is seeing lower case shipment growth. Neutral rating. Align Technology numbers lowered at Jefferies. Shares of ALGN now seen reaching $34, Jefferies said. Estimates also lowered on rare 3Q shortfall. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV